{"organizations": ["Immunomic Therapeutics"], "uuid": "db973ad2d98666a265ce97c468fff6300ec1c95a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.newsdump.com", "main_image": "", "site_section": "http://www.newsdump.com/feed/", "section_title": "NewsDump.com, US News, Headlines, Latest USA News, US Sports, US Politics, Football, Business, Celebs, Baseball, Hockey, Basketball", "url": "http://www.newsdump.com/article/immunomic-therapeutics-licenses-hopkinsdeveloped-vaccine-technology-for-300-million", "country": "CZ", "title": "Immunomic Therapeutics licenses Hopkins-developed vaccine technology for $300 million", "performance_score": 0, "site": "newsdump.com", "participants_count": 0, "title_full": "Immunomic Therapeutics licenses Hopkins-developed vaccine technology for $300 million", "spam_score": 0.0, "site_type": "news", "published": "2015-10-10T00:27:00.000+03:00", "replies_count": 0, "uuid": "db973ad2d98666a265ce97c468fff6300ec1c95a"}, "author": "", "url": "http://www.newsdump.com/article/immunomic-therapeutics-licenses-hopkinsdeveloped-vaccine-technology-for-300-million", "ord_in_thread": 0, "title": "Immunomic Therapeutics licenses Hopkins-developed vaccine technology for $300 million", "locations": ["Baltimore"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Published By: Baltimore Sun: Health - Today \nImmunomic Therapeutics, a biotechnology company developing a new type of vaccine based on Johns Hopkins research, has reached a $300 million...", "external_links": [], "published": "2015-10-10T00:27:00.000+03:00", "crawled": "2015-10-10T02:36:23.077+03:00", "highlightTitle": ""}